The Regulation of Hybrids and Chimeras in the UK

Beyleveld, D.; Finnegan, T.; Pattinson, Shaun D.

Abstract

In this report, we will, for the most part, sidestep discussion of how “chimeras” and “hybrids” are to be defined and distinguished, by simply focusing on the UK’s regulation of the activities that CHIMBRIDS has identified as its concern. These are activities that involve “the fusion of human and non-human tissue and cells”, and include human/non-human: * transplantation (i.e. xenotransplantation) * gamete mixing * somatic cell nuclear transfer (into an enucleated ovum) * zygote genetic modification * embryonic cell transfer/fusion. We will address each of these possibilities before addressing patent regulation and the wider ethico-cultural background of the UK regulatory position.

Citation

Beyleveld, D., Finnegan, T., & Pattinson, S. D. (2009). The Regulation of Hybrids and Chimeras in the UK. In J. Taupitz, & M. Weschka (Eds.), Chimbrids : chimeras and hybrids in comparative European and international research : scientific, ethical, philosophical and legal aspects (603-825). Springer Verlag. https://doi.org/10.1007/978-3-540-93869-9_25

• Publication Date: Jan 1, 2009
• Deposit Date: Jan 26, 2012
• Publicly Available Date: Sep 11, 2012
• Publisher: Springer Verlag
• Pages: 603-825
• Series Title: Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim
• Book Title: Chimbrids : chimeras and hybrids in comparative European and international research : scientific, ethical, philosophical and legal aspects.
• Chapter Number: Annex A.III.2
• DOI: https://doi.org/10.1007/978-3-540-93869-9_25
• Public URL: https://durham-repository.worktribe.com/output/1662415